{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T10:59:12Z","timestamp":1789556352224,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Alpha-methylacyl-CoA racemase (AMACR) deficiency is a rare peroxisomal enzyme deficiency caused by biallelic variants in the <jats:italic>AMACR<\/jats:italic> gene. This deficiency leads to the accumulation of toxic bile acid intermediates (<jats:italic>R<\/jats:italic>)-trihydroxycholestenoic acid (THCA) and (<jats:italic>R<\/jats:italic>)-dihydroxycholestenoic acid (DHCA) and pristanic acid. With less than 20 patients described in literature, the phenotype of AMACR deficiency is poorly defined and no data on the natural history are available.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Here we describe a cohort of 12 patients (9 adults and 3 children) with genetically confirmed AMACR deficiency (median age at diagnosis 56 years, range 3\u201369), followed for an average of 6 years (between 2015 and 2023). Five novel pathogenic variants are described. In 5\/9 adult patients, retinitis pigmentosa was detected at a median age of 45 years (range 30\u201361). The median delay to diagnosis of AMACR deficiency after the diagnosis of retinitis pigmentosa was 24 years (range 0\u201333). All adult patients subsequently developed neurological signs and symptoms after the age of 40 years; most frequently neuropathy, ataxia and cognitive decline with prior normal cognitive functioning. One patient presented with a stroke-like episode. All adult patients showed a typical MRI pattern involving the thalami and gray matter structures of the pons and midbrain. One patient had a hepatocellular carcinoma at the time of the AMACR deficiency diagnosis and two patients suffered from gallstones. All three included children had elevated liver transaminases as single presenting sign and showed no brain MRI abnormalities.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>AMACR deficiency can be considered as an adult slowly progressive disease with a predominant neurological phenotype. The main signs comprise retinitis pigmentosa, neuropathy, ataxia and cognitive decline; stroke-like episodes may occur. Recognition of typical MRI abnormalities may facilitate prompt diagnosis. In addition, there is a risk of liver fibrosis\/cirrhosis and hepatocellular carcinoma in these patients, requiring active monitoring.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-024-03358-9","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T12:01:32Z","timestamp":1727092892000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Redefining the phenotype of alpha-methylacyl-CoA racemase (AMACR) deficiency"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8552-8837","authenticated-orcid":false,"given":"Femke C.C.","family":"Klouwer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan D.","family":"Roosendaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla E. M.","family":"Hollak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam","family":"Langeveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bwee Tien","family":"Poll-The","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlette J. van","family":"Sorge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole I.","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjo S. van der","family":"Knaap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Engelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,23]]},"reference":[{"key":"3358_CR1","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/72861","volume":"24","author":"S Ferdinandusse","year":"2000","unstructured":"Ferdinandusse S, et al. Mutations in the gene encoding peroxisomal alpha-methylacyl-CoA racemase cause adult-onset sensory motor neuropathy. Nat Genet. 2000;24:188\u201391.","journal-title":"Nat Genet"},{"key":"3358_CR2","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.bbamcr.2015.11.015","volume":"1863","author":"HR Waterham","year":"2016","unstructured":"Waterham HR, Ferdinandusse S, Wanders RJA. Human disorders of peroxisome metabolism and biogenesis. Biochim Biophys Acta - Mol Cell Res. 2016;1863:922\u201333.","journal-title":"Biochim Biophys Acta - Mol Cell Res"},{"key":"3358_CR3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ymgme.2008.11.165","volume":"96","author":"S Ferdinandusse","year":"2009","unstructured":"Ferdinandusse S, Denis S, Dacremont G, Wanders RJ. A. Toxicity of peroxisomal C27-bile acid intermediates. Mol Genet Metab. 2009;96:121\u20138.","journal-title":"Mol Genet Metab"},{"key":"3358_CR4","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1194\/jlr.R900009-JLR200","volume":"50","author":"S Ferdinandusse","year":"2009","unstructured":"Ferdinandusse S, Denis S, Faust PL, Wanders RJ. A. bile acids: the role of peroxisomes. J Lipid Res. 2009;50:2139\u201347.","journal-title":"J Lipid Res"},{"key":"3358_CR5","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s10545-016-9962-9","volume":"39","author":"K Berendse","year":"2016","unstructured":"Berendse K, et al. Cholic acid therapy in Zellweger spectrum disorders. J Inherit Metab Dis. 2016;39:859\u201368.","journal-title":"J Inherit Metab Dis"},{"key":"3358_CR6","doi-asserted-by":"crossref","unstructured":"Klouwer FCC et al. Clinical and biochemical pitfalls in the diagnosis of Peroxisomal disorders. Neuropediatrics 47, (2016).","DOI":"10.1055\/s-0036-1582140"},{"issue":"Suppl 3","key":"3358_CR7","doi-asserted-by":"publisher","first-page":"S349","DOI":"10.1007\/s10545-010-9183-6","volume":"33","author":"EH Smith","year":"2010","unstructured":"Smith EH, et al. An adult onset case of alpha-methyl-acyl-CoA racemase deficiency. J Inherit Metab Dis. 2010;33(Suppl 3):S349\u201353.","journal-title":"J Inherit Metab Dis"},{"key":"3358_CR8","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1136\/jnnp.2007.129478","volume":"79","author":"SA Thompson","year":"2008","unstructured":"Thompson SA, et al. Relapsing encephalopathy in a patient with alpha-methylacyl-CoA racemase deficiency. J Neurol Neurosurg Psychiatry. 2008;79:448\u201350.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3358_CR9","doi-asserted-by":"publisher","first-page":"e247964","DOI":"10.1136\/bcr-2021-247964","volume":"15","author":"MJ Tanti","year":"2022","unstructured":"Tanti MJ, Maguire MJ, Warren DJ, Bamford J. Late onset AMACR deficiency with metabolic stroke-like episodes and seizures. BMJ Case Rep CP. 2022;15:e247964.","journal-title":"BMJ Case Rep CP"},{"key":"3358_CR10","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/ene.14588","volume":"28","author":"B Krett","year":"2021","unstructured":"Krett B, Straub V, Vissing J. Episodic hyperCKaemia may be a feature of \u03b1-methylacyl-coenzyme A racemase deficiency. Eur J Neurol. 2021;28:729\u201331.","journal-title":"Eur J Neurol"},{"key":"3358_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1172-8-1","volume":"8","author":"K Haugarvoll","year":"2013","unstructured":"Haugarvoll K, et al. MRI characterisation of adult onset alpha-methylacyl-coa racemase deficiency diagnosed by exome sequencing. Orphanet J Rare Dis. 2013;8:1.","journal-title":"Orphanet J Rare Dis"},{"key":"3358_CR12","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1212\/WNL.0b013e31821a4484","volume":"76","author":"D Dick","year":"2011","unstructured":"Dick D, Horvath R, Chinnery PF. AMACR mutations cause late-onset autosomal recessive cerebellar ataxia. Neurology. 2011;76:1768\u201370.","journal-title":"Neurology"},{"key":"3358_CR13","doi-asserted-by":"publisher","first-page":"289","DOI":"10.24953\/turkjped.2019.02.023","volume":"61","author":"M G\u00fcnd\u00fcz","year":"2019","unstructured":"G\u00fcnd\u00fcz M, \u00dcnal \u00d6, K\u00fc\u00e7\u00fck\u00e7ongar-Yava\u015f A, Kasapkara \u00c7. Alpha methyl acyl CoA racemase deficiency: diagnosis with isolated elevated liver enzymes. Turk J Pediatr. 2019;61:289\u201391.","journal-title":"Turk J Pediatr"},{"key":"3358_CR14","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1053\/gast.2003.50017","volume":"124","author":"KDR Setchell","year":"2003","unstructured":"Setchell KDR, et al. Liver disease caused by failure to racemize trihydroxycholestanoic acid: gene mutation and effect of bile acid therapy. Gastroenterology. 2003;124:217\u201332.","journal-title":"Gastroenterology"},{"key":"3358_CR15","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1212\/01.WNL.0000132841.81250.B7","volume":"63","author":"CE Clarke","year":"2004","unstructured":"Clarke CE, et al. Tremor and deep white matter changes in alpha-methylacyl-CoA racemase deficiency. Neurology. 2004;63:188\u20139.","journal-title":"Neurology"},{"key":"3358_CR16","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1212\/WNL.0b013e3181f612a5","volume":"75","author":"V Kapina","year":"2010","unstructured":"Kapina V, et al. Relapsing rhabdomyolysis due to peroxisomal alpha-methylacyl-coa racemase deficiency. Neurology. 2010;75:1300\u20132.","journal-title":"Neurology"},{"key":"3358_CR17","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.1002\/ajmg.a.35611","volume":"158A","author":"JMA Verhagen","year":"2012","unstructured":"Verhagen JMA, et al. Incidental finding of alpha-methylacyl-CoA racemase deficiency in a patient with oculocutaneous albinism type 4. Am J Med Genet A. 2012;158A:2931\u20134.","journal-title":"Am J Med Genet A"},{"key":"3358_CR18","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1097\/ICB.0b013e3181f047dd","volume":"5","author":"M Stewart","year":"2011","unstructured":"Stewart M, Vavra M, Whaley N. Fundus findings in a patient with \u03b1-methylacyl-CoA racemase deficiency. Retin Cases Br Rep. 2011;5:262\u20136.","journal-title":"Retin Cases Br Rep"},{"key":"3358_CR19","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1023\/A:1005543802724","volume":"22","author":"AH Bootsma","year":"1999","unstructured":"Bootsma AH, et al. Rapid analysis of conjugated bile acids in plasma using electrospray tandem mass spectrometry: application for selective screening of peroxisomal disorders. J Inherit Metab Dis. 1999;22:307\u201310.","journal-title":"J Inherit Metab Dis"},{"key":"3358_CR20","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/j.bbamcr.2006.09.001","volume":"1763","author":"S Ferdinandusse","year":"2006","unstructured":"Ferdinandusse S, Houten SM. Peroxisomes and bile acid biosynthesis. Biochim Biophys Acta. 2006;1763:1427\u201340.","journal-title":"Biochim Biophys Acta"},{"key":"3358_CR21","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1097\/MPG.0b013e31812e56ff","volume":"45","author":"V de L\u00e9dinghen","year":"2007","unstructured":"de L\u00e9dinghen V, et al. Liver stiffness measurement in children using FibroScan: feasibility study and comparison with Fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy. J Pediatr Gastroenterol Nutr. 2007;45:443\u201350.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"3358_CR22","doi-asserted-by":"publisher","first-page":"777","DOI":"10.3174\/ajnr.A6542","volume":"41","author":"TM Shepherd","year":"2020","unstructured":"Shepherd TM, Ades-Aron B, Bruno M, Schambra HM, Hoch MJ. Direct in vivo MRI discrimination of brain stem nuclei and pathways. AJNR Am J Neuroradiol. 2020;41:777\u201384.","journal-title":"AJNR Am J Neuroradiol"},{"key":"3358_CR23","first-page":"131","volume":"113","author":"SW Cheo","year":"2019","unstructured":"Cheo SW, Low QJ, Tan YA, Chia YK. Trident sign in osmotic demyelination syndrome. QJM Int J Med. 2019;113:131\u20132.","journal-title":"QJM Int J Med"},{"key":"3358_CR24","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1053\/j.gastro.2004.09.014","volume":"127","author":"G Fattovich","year":"2004","unstructured":"Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterol. 2004;127:S35\u201350.","journal-title":"Gastroenterol"},{"key":"3358_CR25","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/jimd.12042","volume":"42","author":"FCC Klouwer","year":"2019","unstructured":"Klouwer FCC, et al. The cholic acid extension study in Zellweger spectrum disorders: results and implications for therapy. J Inherit Metab Dis. 2019;42:303\u201312.","journal-title":"J Inherit Metab Dis"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03358-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-024-03358-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03358-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T12:02:48Z","timestamp":1727092968000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-024-03358-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,23]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3358"],"URL":"https:\/\/doi.org\/10.1186\/s13023-024-03358-9","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,23]]},"assertion":[{"value":"3 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval of the Research Ethics Committee was not required, since all measurements were performed as part of standard patient care.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from all patients or their legal representative.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"350"}}